Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Urologic Diseases 1Urinary Retention 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Prostatic Neoplasms 1Patient Satisfaction 1Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Hematuria 1

Interventions

eltrombopag 3romiplostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Busulfan 2Vitamin E 1Tranexamic Acid 1Topotecan 1Thrombopoietin 1Saline Solution 1Radiotherapy 1Moxibustion 1Microarray Analysis 1Isotretinoin 1Ifosfamide 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Doxorubicin 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cord Blood Stem Cell Transplantation 1Carboplatin 1CP protocol 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Thrombocytopenia × Tranexamic Acid × Clear all
NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡